Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics - Summary - MDSpire

Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

  • July 16, 2026

Share

Objective:

To announce the retraction of a previously published research article due to concerns regarding data validity.

Approach:
  • Retraction Process: The article was retracted following an investigation by the Frontiers Research Integrity Auditing team, which identified issues with the validity of the data.
Key Findings:
  • The authors did not provide raw data or a satisfactory explanation during the investigation.
  • The editors lost confidence in the findings presented in the article.
Interpretation:

The retraction was approved by the Chief Editors of Frontiers in Medicine and the Chief Executive Editor of Frontiers.

Limitations:
  • The authors did not respond to any correspondence regarding the retraction.
Conclusion:

The article has been officially retracted due to concerns about data integrity.

Sources:

Original Source(s)

Retraction: Integrative analysis of serum microorganisms and serum metabolomics in osteoporosis patients based on 16S rDNA sequencing and UHPLC/MS-based metabolomics

  • July 16, 2026

Related Content

OI Therapy Raised BMD, Not Fracture Benefit

Teriparatide followed by zoledronic acid increased bone mineral density but did not reduce fracture risk compared with standard care in adults with osteogenesis imperfecta.

Research progress on the intervention of osteoporosis by Chinese herbal monomers based on the Nrf2/NF-κB/MAPK pathway

Duration-Dependent Adverse Events of Systemic Glucocorticosteroids in Atopic Dermatitis: A Nationwide Claims Cohort Study